..., such as sex and deprivation, may play a role in who survives a NET diagnosis. This systematic review identifies the available evidence assessing the impact of sex and deprivation on the prognosis of patients diagnosed with NETs. Summary: Using protocol-driven search terms, Embase and Ovid were searched...

..., functioning syndromes, prognosis, and response/toxicity to treatments in L-NETs according to sex. Results: Female patients are more likely to have an L-NET than males. The reasons underlying these gender differences are still unclear; a biologic mechanism for the sex difference is possible, through a role...

...: Although neuroendocrine neoplasms (NENs) have a good prognosis, distant metastasis remains a crucial prognostic factor. Survivin, a tumor-associated antigen, is overexpressed in several solid tumors, indicating poor prognosis. We aimed to evaluate the clinical significance and role of survivin...

... tumors Peptide receptor radionuclide therapy Peripheral blood RNA-Seq Cancer hallmarks Prognosis Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) arise from the diffused neuroendocrine system located along the gastrointestinal tract and in the pancreas [ 1, 2 ]. These typically...

.../previous smokers ( p = 0.51). In the follow-up period, only 2 (9%) of the 22 recurrences were found on a routine bronchoscopy. Both of these recurrences were also found by diagnostic imaging. Conclusions: Surgical treatment, especially, and diagnosis of TC were associated with a good prognosis. Furthermore...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Mast cell Pancreatic neuroendocrine neoplasm Tumor-infiltrating immune cells Tumor microenvironment Prognosis Pancreatic neuroendocrine neoplasms (PanNENs) are a group...

... in current smokers ( p = 0.029). Discussion/Conclusion: cfDNA levels are higher in NET patients than in healthy controls; however, there was no association with prognosis, and cfDNA levels were unaffected by PRRT. Our observations suggest that cfDNA levels are not associated with the disease course in low...

.... Neuroendocrine tumors Prognosis Biomarkers Reproducibility of results Neuroendocrine tumors (NETs) represent a very heterogeneous group of neoplasms that arise from the diffuse endocrine system. The primary tumor may be located in many different organ systems, most frequently in the lungs bronchi...

..., instructions or products referred to in the content or advertisements. 2019 Neuroendocrine tumor Metastatic neuroendocrine tumor Elderly Prognosis Treatment Neuroendocrine tumors (NETs) are rare and include a heterogeneous group of neoplasms derived from the gastrointestinal tract...

..., instructions or products referred to in the content or advertisements. Biomarkers Carcinoid Ki-67 NETest Neuroendocrine neoplasia Neuroendocrine tumors Prognosis Progression Neuroendocrine tumors (NETs) represent a diverse and heterogeneous group of neoplastic lesions with widely different...

... carcinoids. [email protected] 26 08 2019 9 02 2020 11 2 2020 Lung Carcinoid Biomarker KLF12 Prognosis 2020 S. Karger AG, Basel 2020 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...

... was significant on UV ( p < 0.00001) but not MV ( p = 0.76). Tumours of higher grade had higher MTV (mean MTV – G1: 39.6 mL, G2: 107 mL, G3: 337 mL; p = 0.0001 by ANOVA). Conclusions: Quantitative analysis of 18 F-FDG PET in NEN is feasible. High MTV/TLG are predictors of poor prognosis in NEN. Further...

... a more aggressive biology correlate with prognosis. The purpose of this study was to characterize changes in PanNET differentiation and proliferation over time and to correlate findings to overall survival (OS). Patients and Methods: In this retrospective cohort study, we screened 475 PanNET patients...

... Prognosis Second cancer Radiation therapy is an important part of the therapeutic arsenal against cancer with up to 50% of cancer patients receiving radiation therapy as part of their treatment [ 1 ]. Although radiation therapy has allowed increasing overall survival and local control in patients...

... make up approximately 75% of the cases and have an excellent prognosis, with a 5-year survival rate approximately 90%, while ACs represent 25% of the cases and have a worse prognosis, with a 5-year survival rate between 40 and 70% [ 1 ]. Around 20% of patients with AC present with advanced disease...

.... Bronchopulmonary Lung Chromogranin A Biomarker Carcinoid Diagnosis Prognosis Cancer biomarkers are essential for the identification of disease and as tools to quantify disease progression (PD) and outcome. Numerous types of biomarkers have been proposed and studied [ 1 ]. Among these, dysregulated...

... with intermediate prognosis, and various rare tumor types. Histologic differentiation, proliferative grade, size, level of gastric wall invasion, and local or distant metastases are used as prognostic markers. However, their value remains to be tailored to specific gastric NENs. Methods: Series of type I NETs ( n...

... Therapy Prognosis Based on the local database of the ENETS center of the University of Marburg, Germany, 677 patients treated at the hospital between January 1, 2000 and June 1, 2015 were identified for inclusion in this retrospective study. 327 of these 677 patients presented with distant...

... malignancies depending on the metastatic potential of the tumour components. High-grade malignant component should be considered even if it represents <30% of the tumour. The prognosis of MiNEN is generally intermediate between those of the two “pure” components composing it. The aim of this comprehensive...

... Neuroendocrine carcinoma Morphology Proliferation Classification Prognosis Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of neoplastic proliferations encompassing a wide spectrum of entities ranging from low proliferative well-differentiated neuroendocrine...